. "Appendix D-5: The Prospects for Immunizing Against Hepatitis B Virus." New Vaccine Development: Establishing Priorities: Volume II, Diseases of Importance in Developing Countries. Washington, DC: The National Academies Press, 1986.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Vaccine Development: Establishing Priorities, Volume II, Diseases of Importance in Developing Countries
Smith, G.L., M.Mackett, and B.Moss. 1983. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 302(5908):490–495.
Stevens, C.E., R.P.Beasley, J.Tsui, and W.C.Lee. 1975. Vertical transmission of hepatitis B antigen in Taiwan. N. Engl. J. Med. 292(15):771–774.
Szmuness, W., C.E.Stevens, E.J.Harley, E.A.Zang, W.R.Oleszko, D.C. William, R.Sadovsky, J.N.Morrison, and A.Kellner. 1980. Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high risk population in the United States. N. Engl. J. Med. 303:833–841.
Valenzuela, P., P.Gray, M.Quiroga, J.Zaldivar, H.M.Goodman, and W.J.Rutter. 1979. Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature 280(5725):815–819.
Xu, Z.-Y., C.-B. Liu, D.P.Francis, R.H.Purcell, Z.L.Gun, S.C.Duan, R.J.Chen, H.S.Margolis, C.H.Huang, and J.E.Maynard. 1985. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: Preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Pediatrics 76:713–718.
